Brief: Shedir Pharma H1 Prelim. Revenue From Sales Up 26% To EUR 23.3 Mln
July 19 (Reuters) - Shedir Pharma Srl Unipersonale SHE.MI :
* SHEDIR PHARMA - H1 PRELIM. REVENUE FROM SALES EUR 23.3
MILLION,
UP 26% VERSUS EUR 18.5 MILLION YEAR AGO
Further company coverage: SHE.MI
(Reporting by Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Shedir Pharma Srl Unipersonale
See all newsBrief: Dimainvest Reaches 98.088% Of Shedir Pharma, Company To Delist On Jan 23
Brief: Shedir Pharma Says Subscription Period Ends For Dimainvest Offer
Italy - Factors to watch on Jan. 10
Brief: Dimainvest Says It Reached 90% Threshold In Shedir Pharma Takeover Bid
Brief: Dimainvest Launches Takeover Bid For Shedir Pharma